Compatibility studies 6-10 Fourier Transform Infrared Spectroscopy FTIR spectra of the pure drug, excipients, and prepared solid dispersions were obtained on a FTIR. Samples were prepared in KBr disks (2 mg sample in 200 mg KBr). The scanning range was 400-4000 cm−1, and the resolution was 1 cm−1.
INTRODUCTION
There are quite a number of patients find it hard to swallow tablets as there is physiological changes associated with people especially elderly and pediatrics. Therefore, in order to solve this problem, this project is conducted so that the patients compliance can be improved, a new dosage form convenient for use by geriatric and pediatric dysphagic patients are formulated; reduce the cost of medication for those patients who cannot afford, and also to produce improved products which are available in the market. [1] [2] [3] [4] [5] Dexamethasone, an antiemetic drug which is model drug mostly used as an antiemetic for post-operative and patients undergo chemotherapy. Dexamethasone has a central antiemetic action through activation of glucocorticoid receptors in bilateral nucleus tractus solitarii. The dose that was being chosen are 4mg. The chemical formula of dexamethasone is C22H29FO5.
MATERIALS AND METHODS
Dexamethasone, Croscarmellose sodium and guar gum were purchased from Sigma-Aldrich MALAYSIA. Other excipients such as mannitol, sucralose, starch, vanillin and magnesium stearate used and all other reagents used were of analytical grade.
Determination of λ max of Dexamethasone and preparation of calibration curve
Dexamethasone 10 mg was weighed accurately and was completely dissolved in methanol in volumetric flask. The solution was then topped up to 100 ml with methanol to give concentration of 0.1mg/ml. Then, 1ml was pipetted out from the flask and again topped up to 100ml with methanol to give concentration of 1 µg/ml. Aliquots of 1 ml, 2 ml, 3 ml, 4 ml, 5 ml and 6 ml were pipetted out in 10ml volumetric flask. 10, 11 The volume was diluted with methanol to give concentration of 0.1, 0.2, 0.3, 0.4, 0.5 and 0.6 µg/ml dexamethasone respectively. A best UV wavelength (λmax) was selected by using spectroscopic scanning run (200-400 nm) with the reference solution and was found to be 239nm.
Formulation of Mouth Dissolving Tablets
Dexamethasone, natural Super disintegrants, mannitol, magnesium stearate, starch, sucralose and vanillin are being mixed uniformly using geometric trituration and also being weighed accurately prior to compression. Then, a manual tablet compression machine with manual 7 mm single punch was used to compress powder into tablet form. Powder mixture of 150 mg is weighed accurately and added into the die cavity. Lastly, tablets of 150 mg each was produced after compression by the machine. [7] [8] [9] The composition of dexamethasone mdt is shown in Table 1 . 
Physicochemical Evaluation of Mouth Dissolving Tablets 7-11 Weight Variation
Ten tablets were selected randomly from each batch and weighed individually to check for weight variation. The following percentage deviation in weight variation is allowed as per USP.
Thickness
Vernier calipers was being used to measure the thickness.
Hardness
Monsanto hardness tester Hardness was used to determine the hardness of tablets.
Friability
Ten tablets were accurately weighed and placed in the friabilator and undergo 100 revolutions. Percentage friability was calculated using the following formula. F= (1-W0/W) × 100, Where, W0 is the weight of the tablet before the test and W is the weight of the tablet after the test.
Disintegration Time
Three tablets were being taken and being placed into each tube of USP disintegration apparatus (distilled water 900 ml at 37°C) as the disintegrating medium. The experiment was being done in room temperature.
Wetting Time
Three tablets were being taken for this test. A petri dish was filled up with 10ml of distilled water. Then, a tissue paper folded twice was placed into the petri dish. The time to for the tablet to wet completely was observed after a tablet was placed on the paper.
In-vitro Dispersion Time
Three tablets were taken for this test. 6ml phosphate buffer solution, pH 6.8 ±0.5°C was prepared before each tablet was being placed. Then, the time for complete dispersion of a tablet was observed.
Water Absorption Ratio
A petri dish was filled up with 10ml of distilled water. Then, a tissue paper folded twice was placed into the petri dish. A tablet was placed on top of the paper and pre-weight of tablets was determined. Then, the tablet which was wet are weighed. Water absorption ratio R, was determined using equation.
R= {(Wa-Wb) / Wb} × 100 Where, Wa= weight of the tablet before water absorption Wb= weight of the tablet after water absorption. Three tablets from each formulation were analyzed and standard deviation was determined. The results were shown in table 2.
In-vitro Drug Release 11
Three tablets from each formulation were being placed into the Electro lab TDT-08L Dissolution Tester. The medium used were 900ml of phosphate buffer pH 6.8 for MDT and 500ml of dilute HCL buffer for conventional marketed Dexamethasone tablets. Temperature was set at 37±0.5 °C; speed at 50 cycles per minute; sample interval was 5min, 10min, 15min, 30min, 45 min and 1 hour; sample volume was 5ml, replacing the aliquots with fresh buffer solution after withdrawing. The drug release and different kinetic models were shown in Table 3 and 
RESULTS AND DISCUSSION
There was no interaction between the drug and natural Super disintegrants according to the results obtained from FTIR and DSC and it shows that drug and polymer are compatible each other. Thickness found was in the range of 2.5-3.0 mm, hardness was between 2-3 kg/cm 2 and it is important for MDT for achieving fast disintegration, weight variation found to be in between 146.7 mg-129.1 mg, friability between 0.57 %-0.98 %, disintegration time between 38.33 -63 seconds and it shows that MDT can disintegrate quickly without access of water, wetting time between 47-160seconds, in-vitro dispersion time between 34.33-119 seconds, water absorption ratio between 0.55 %-0.9 4%. All these parameters are shows that dexamethasone is ideal candidate for delivering as mouth dissolving tablet and all physicochemical parameters were in control limits.
The % drug release for all formulation was between 99.36%-106.39%. The release profile showed that formulation containing natural Super disintegrants has higher and faster % drug release compared to conventional Dexamethasone tablets. The higher the concentration of natural Super disintegrants, the faster the % drug release and the order of drug release is 1%<2%<3%.
In-vitro drug release was compared with marketed product of conventional dexamethasone tablet and dexamethasone mdt was showing better and faster drug release than marketed product. In-vitro drug release was compared with marketed product of conventional dexamethasone tablet and dexamethasone mdt was showing better and faster drug release than marketed product. Kinetics of drug release of dexamethasone MDT shows that diffusional exponent, n is less than 0.45 and followed fickian diffusion order of drug release.
CONCLUSION
Tablets and capsules which are currently being considered as the most popular dosage form for oral delivery have some disadvantages to patients undergoing chemotherapy and patients having dysphagia problem. Hence to overcome this problem, current research on Dexamethasone 
